Overcoming barriers of cervical cancer elimination in India: A practice to policy level advocacy

• Published in: Journal of cancer policy 2025-03, Vol.43, p.100521, Article 100521
• Main Authors: Poddar, Abhijit, Rao, S.R.
• Format: Article
• Language: English
• Subjects: Cervical cancer; HPV; India; Policy; Practice; Predisposing factors; Vaccination
• ISSN: 2213-5383; 2213-5383
• DOI: 10.1016/j.jcpo.2024.100521

India’s ambitious goal of eliminating cervical cancer by 2030 faces significant challenges due to the high burden of disease, low screening rates, and sociocultural barriers. Despite the Government’s focus on vaccination, addressing cervical cancer requires a more comprehensive approach that is multisectoral and consider practice to policy engagement. Addressing not only vaccination but also social barriers, healthcare infrastructure, and research is key to preventing and controlling this preventable disease. Fragmented health policies with limited coverage for cervical cancer, coupled with societal issues like stigma and limited access to healthcare, particularly in rural areas, pose significant challenges. Moreover, limited awareness of HPV and vaccines hinders progress. To effectively combat cervical cancer, India must prioritize a readiness assessment to evaluate past interventions, economic feasibility, and social issues before launching new programs. Improving healthcare infrastructure, training healthcare workers, and utilizing innovative models like mobile clinics can expand access to care. Public-private partnerships with incentives can also play a crucial role in mobilizing resources. Investing in culturally appropriate public awareness campaigns is essential to educate the population about HPV, cervical cancer, and prevention strategies. A robust pharmacovigilance program is necessary to ensure vaccine safety. Additionally, India should invest in science and technology to support long-term research efforts, while increasing understanding of population-specific predisposing factors for broader-spectrum vaccines and personalized approaches. A dedicated national policy with clear objectives, strategies, and accountability mechanisms is crucial for successful cervical cancer control. Learning from the experiences of other countries can inform policy development. •Cervical cancer is the second most prevalent cancer in India.•India has a limited understanding of predisposing population-based risk factors.•India lacks a dedicated policy and also has central-state disparities.•The current focus on vaccines ignores scientific, social, and delivery challenges.•India must improve the practice-to-policy landscape through multisectoral approaches.